Medical Device reimbursement levels in Japan are now more in line with the reimbursement levels in the EU. The Japanese ...

Japan's Ministry of Health, Labor and Welfare's (MHLW) Narcotics Control Division updated its guidelines on THC limits for ...

Eli Lilly has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for Kisunla (donanemab-azbt) to treat early symptomatic Alzheimer's disease. A prescription medicine ...

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

Takeda has secured approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its 1mg/5mg FRUZAQLA capsules ...

The Ministry of Health, Labour and Welfare (MHLW) in Japan has cleared Ezharmia (valemetostat tosylate) based on the results of an open-label phase 2 trial which revealed a 48% overall response ...

The application to the Ministry of Health, Labour and Welfare (MHLW) is set for a priority review, reflecting the relatively high incidence of biliary tract cancer in Japan relative to other ...

To this end, mortality data was extracted from life tables published by the Ministry of Health, Labor, and Welfare (MHLW), and psychological distress data was taken from the Comprehensive Survey ...

Tokyo, Japan and Cambridge, UK, 1 November 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or ...

The therapy received its first global approval from Japan's Ministry of Health, Labour and Welfare (MHLW) in March 2024, and gained subsequent endorsements by the UK's Medicines and Healthcare ...

Japan updated its guidelines on THC limits for CBD products, however some industry experts point out gaps. The European Commission has launched an investigation into Italy’s effort to ban trade ...

To this end, mortality data was extracted from life tables published by the Ministry of Health, Labor, and Welfare (MHLW), and psychological distress data was taken from the Comprehensive Survey ...